[Effects of several neuroblockers on galanin induced inhibitory action of insulin secretion].
Yoshimura
T
T
Manabe
T
T
Tobe
T
T
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D004285:Dogs; D019004:Galanin; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D007329:Insulin Antagonists; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism; D009270:Naloxone / Q000494:pharmacology*; D010276:Parasympatholytics / Q000494:pharmacology*; D010455:Peptides / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D001786:Blood Glucose; D007328:Insulin; D007329:Insulin Antagonists; D010276:Parasympatholytics; D010455:Peptides; D009270:Naloxone; D019004:Galanin